Kissei Pharmaceutical Co., Ltd.

General ticker "KSPHF" information:

  • Sector: Health Care
  • Industry: Drug Manufacturers - Specialty & Generic
  • Capitalization: $1.1B (TTM average)

Kissei Pharmaceutical Co., Ltd. does not follow the US Stock Market performance with the rate: -25.0%.

Estimated limits based on current volatility of 0.0%: low 25.77$, high 25.77$

Factors to consider:

  • Company pays dividends (annually): last record date 2026-03-31, amount 0.63$ (Y2.44%)
  • Earnings for 12 months up through Q4 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-03-31 to 2027-03-31

  • 2025-03-31 to 2026-03-31 estimated range: [19.98$, 28.68$]
  • 2026-03-31 to 2027-03-31 estimated range: [19.96$, 28.93$]

Financial Metrics affecting the KSPHF estimates:

  • Positive: with PPE of 13.5 at the end of fiscal year the price was neutral
  • Positive: -4.17 < Operating profit margin, % of 6.54
  • Negative: negative Industry operating cash flow (median)
  • Positive: 1.89 < Return on assets ratio (scaled to [-100,100]) of 4.67
  • Positive: Investing cash flow per share per price, % of 3.17 > -0.65
  • Negative: Operating cash flow per share per price, % of 4.18 <= 6.73
  • Negative: Shareholder equity ratio, % of 85.64 > 63.79
  • Negative: -0.76 < Inventory ratio change, % of 0

Similar symbols

Short-term KSPHF quotes

Long-term KSPHF plot with estimates

Financial data

YTD 2024-03-31 2025-03-31
Operating Revenue ¥75,579.00MM ¥88,330.00MM
Operating Expenses ¥71,562.00MM ¥82,557.00MM
Operating Income ¥4,017.00MM ¥5,773.00MM
Non-Operating Income ¥10,432.00MM ¥9,837.00MM
Interest Expense ¥18.00MM ¥21.00MM
Income(Loss) ¥14,449.00MM ¥15,610.00MM
Taxes ¥3,159.00MM ¥3,634.00MM
Net Income(Loss)* ¥11,160.00MM ¥11,961.00MM
Stockholders Equity ¥220,029.00MM ¥209,003.00MM
Assets ¥260,929.00MM ¥244,059.00MM
Operating Cash Flow ¥-1,677.00MM ¥6,521.00MM
Capital expenditure ¥1,833.00MM ¥5,030.00MM
Investing Cash Flow ¥8,690.00MM ¥4,952.00MM
Financing Cash Flow ¥-10,006.00MM ¥-9,325.00MM
Earnings Per Share** ¥246.59 ¥274.21

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.